Invention Grant
- Patent Title: Antibodies specific for DR5 and methods of use
-
Application No.: US15913713Application Date: 2018-03-06
-
Publication No.: US11214622B2Publication Date: 2022-01-04
- Inventor: Peter Bruenker , Sherif Daouti , Ningping Feng , Claudia Ferrara Koller , Guy Georges , Sandra Grau-Richards , Ralf Hosse , Christian Klein , Maximiliane Koenig , Joerg Moelleken , Ekkehard Moessner , Huifeng Niu , Kathryn E. Packman , Valeria Runza , Stefan Seeber , Pablo Umana , Inja Waldhauer , Huisheng Wang , Barbara Weiser
- Applicant: Roche Glycart AG
- Applicant Address: CH Schlieren
- Assignee: Roche Glycart AG
- Current Assignee: Roche Glycart AG
- Current Assignee Address: CH Schlieren
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/28 ; C07K16/30 ; A61K39/00 ; C07K16/40
Abstract:
The present invention relates to bispecific antibodies comprising at least one antigen binding site specific for DR5 and at least one antigen binding site specific for FAP, antibodies specific for DR5, methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.
Public/Granted literature
- US20190062453A1 BISPECIFIC ANTIBODIES SPECIFIC FOR FAP AND DR5, ANTIBODIES SPECIFIC FOR DR5 AND METHODS OF USE Public/Granted day:2019-02-28
Information query
